HARMONIC 5MM LAP SHEARS
Report
- Report Number
- 3005075853-2020-00781
- Event Type
- Injury
- Date Received
- February 5, 2020
- Report Date
- January 8, 2020
- Manufacturer
- ETHICON ENDO-SURGERY, LLC.
- Product Code
- GEI
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NY, US
- Reporter Occupation
- OTHER
Narratives
(B)(4). PUBLICATION YEAR OF 2005. BATCH # UNK. THIS REPORT IS RELATED TO A JOURNAL ARTICLE; THEREFORE, NO PRODUCT WILL BE RETURNED FOR ANALYSIS AND THE MANUFACTURING RECORDS CANNOT BE REVIEWED AS THE LOT/BATCH NUMBER HAS NOT BEEN PROVIDED.
TITLE: LAPAROSCOPIC LYMPHADENECTOMY FOR GYNECOLOGIC MALIGNANCIES USING ULTRASONICALLY ACTIVATED SHEARS: ANALYSIS OF FIRST 100 CASES. AUTHORS: FARR NEZHAT, JYOTI YADAV, JAMAL RAHAMAN, HERBERT GRETZ III, GINGER J. GARDNER, CARMEL J. COHEN. CITATION: GYNECOLOGIC ONCOLOGY 97 (2005) 813¿819. DOI:10.1016/J.YGYNO.2005.02.005. THE OBJECTIVE OF THIS STUDY WAS TO EVALUATE THE SAFETY AND EFFICACY OF THE USE OF ULTRASONIC SHEARS IN PERFORMING LAPAROSCOPIC LYMPHADENECTOMY IN A LARGER COHORT OF PATIENTS AT A SINGLE INSTITUTION. THIS PROSPECTIVE STUDY INVOLVES 100 PATIENTS (MEDIAN AGE: 58 YEARS; AGE RANGE: 17-87 YEARS) WHO UNDERWENT LAPAROSCOPIC LYMPHADENECTOMY BETWEEN JANUARY 1999 AND APRIL 2004. ULTRASONIC SHEARS (LCS5, ETHICON) WAS USED AS THE INSTRUMENT FOR DISSECTION AND HEMOSTASIS. REPORTED COMPLICATIONS INCLUDED SIGNIFICANT BLOOD LOSS (N-?), INJURY TO A BRANCH OF THE INFERIOR MESENTERIC ARTERY (N-?) WHICH WAS CONTROLLED WITH BIPOLAR FORCEPS, AND INJURY TO THE RIGHT HYPOGASTRIC VEIN DURING LAPAROSCOPIC PELVIC LYMPHADENECTOMY (N-?) WHICH WAS MANAGED WITH HEMOSTATIC CLIPS. THIS IS THE LARGEST SERIES TO DATE DEMONSTRATING THE SAFETY AND EFFICACY OF ULTRASONIC SHEARS IN LAPAROSCOPIC LYMPHADENECTOMY FOR GYNECOLOGIC MALIGNANCIES.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 133154 | HARMONIC 5MM LAP SHEARS | INSTRUMENT, ULTRASONIC SURGICAL | GEI | ETHICON ENDO-SURGERY, LLC. |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Other |